Soc. Generale Call 243.03 ILMN 20.../ DE000SQ498D1 /
11/8/2024 9:29:53 AM | Chg.0.000 | Bid10:15:02 AM | Ask10:15:02 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid Size: 10,000 |
0.030 Ask Size: 10,000 |
Illumina Inc | 243.03 USD | 12/20/2024 | Call |
GlobeNewswire
8/1
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies i...
GlobeNewswire
7/29
Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactiv...
GlobeNewswire
7/23
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
GlobeNewswire
7/9
Paragon Genomics Partners with Biosecure ID to Expand Access to CleanPlex® Technology in the UK and ...
GlobeNewswire
6/20
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
GlobeNewswire
6/3
AMD Extends AI and High-Performance Leadership in Data Center and PCs with New AMD Instinct, Ryzen a...
GlobeNewswire
5/29
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire
5/9
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alte...
GlobeNewswire
3/4
Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Scre...
GlobeNewswire
2/27
ILLUMINA ALERT: Bragar Eagel & Squire, P.C. is Investigating Illumina, Inc. on Behalf of Long-Term S...
GlobeNewswire
1/9
DEADLINE ALERT for PAYC, ILMN, and JRVR: The Law Offices of Frank R. Cruz Reminds Investors of Class...
GlobeNewswire
1/9
ILMN DEADLINE TODAY: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Illumina, Inc. Investors with Lo...
GlobeNewswire
1/8
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Illumina, Inc. (ILMN) Investors of a Class Action Lawsu...